NYSE ARCA | ETF
The fund invests primarily in equity securities, principally common and preferred stocks of companies of any market capitalization.
Under normal market conditions, the fund invests at least 80% of its net assets, plus borrowings for investment purposes, in securities of companies principally engaged in the research, development, production, or distribution of products and services related to the health care industry ("health care companies").
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ASND | Ascendis Pharma AS | Healthcare | Biotechnology | 15.96% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 15.52% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 6.87% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 5.78% |
| MASI | Masimo Corporation | Healthcare | Medical Devices | 4.71% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 4.65% |
| DXCM | DexCom Inc | Healthcare | Medical Devices | 3.72% |
| SNY | Sanofi ADR | Healthcare | Drug Manufacturers - General | 3.55% |
| PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 3.55% |
| MRUS | Merus BV | Healthcare | Biotechnology | 3.37% |
| HUM | Humana Inc | Healthcare | Healthcare Plans | 2.87% |
| RYTM | Rhythm Pharmaceuticals Inc | Healthcare | Biotechnology | 2.61% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 2.55% |
| ICLR | ICON PLC | Healthcare | Diagnostics & Research | 2.45% |
| 6XC | SOLENO THERAPEUT. DL-001 | Healthcare | Biotechnology | 2.39% |
| CVS | CVS Health Corp | Healthcare | Healthcare Plans | 2.32% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 2.25% |
| WGS | GeneDx Holdings Corp. | Healthcare | Diagnostics & Research | 1.91% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 1.90% |
| PRCT | Procept Biorobotics Corp | Healthcare | Medical Devices | 1.90% |